Sotac Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 18.09 | 13.44 | 16.84 |
| Operating Expense | 16.09 | 10.91 | 14 |
| Net Profit | 0.86 | 1.25 | 1.38 |
| Net Profit Margin | 4.75 | 9.30 | 8.19 |
| Earning Per Share | 0.78 | 1.13 | 1.25 |
| EBIDTA | 2.03 | 2.55 | 2.91 |
| Effective Tax Rate | 16.50 | 17.39 | 19.37 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 18.09 |
| Operating Expense | 16.09 |
| Net Profit | 0.86 |
| Net Profit Margin | 4.75 |
| Earning Per Share | 0.78 |
| EBIDTA | 2.03 |
| Effective Tax Rate | 16.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 57.98 | 73.15 | 43.44 |
| Operating Expenses Annual | 49.77 | 67.00 | 40.58 |
| Operating Profit Annual | 8.45 | 6.36 | 3.21 |
| Interest Annual | 0.86 | 0.55 | 0.61 |
| Depreciation | 1.63 | 1.13 | 1.11 |
| Net Profit Annual | 4.50 | 3.30 | 1.48 |
| Tax Annual | 1.47 | 1.39 | TBA |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 57.98 |
| Operating Expenses Annual | 49.77 |
| Operating Profit Annual | 8.45 |
| Interest Annual | 0.86 |
| Depreciation | 1.63 |
| Net Profit Annual | 4.50 |
| Tax Annual | 1.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.03 | 0.02 | 0.04 |
| Cash Flow from Operations | 8.54 | 3.58 | 2.22 |
| Cash Flow from Investing | -10.93 | -3.28 | -1.07 |
| Cash Flow from Financing | 11.97 | -0.30 | -1.17 |
| Cash Flow at the End | 9.60 | 0.03 | 0.02 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.03 |
| Cash Flow from Operations | 8.54 |
| Cash Flow from Investing | -10.93 |
| Cash Flow from Financing | 11.97 |
| Cash Flow at the End | 9.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 14.64 | 11.25 | 7.39 |
| PBIT Margin (%) | 11.83 | 9.71 | 4.83 |
| PBT Margin (%) | -1.33 | -7.05 | -3.07 |
| Net PROFIT Margin (%) | 7.76 | 4.51 | 3.41 |
| Return On Networth / Equity (%) | 32.04 | 76.91 | 30.77 |
| Return On Networth /Employed (%) | 29.73 | 54.73 | 18.19 |
| Return On Assets (%) | 19.48 | 25.40 | 12.88 |
| Total Debt / Equity (X) | 0.64 | 1.18 | 1.39 |
| Asset Turnover Ratio (%) | 2.51 | 5.63 | 3.78 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 14.64 |
| PBIT Margin (%) | 11.83 |
| PBT Margin (%) | -1.33 |
| Net PROFIT Margin (%) | 7.76 |
| Return On Networth / Equity (%) | 32.04 |
| Return On Networth /Employed (%) | 29.73 |
| Return On Assets (%) | 19.48 |
| Total Debt / Equity (X) | 0.64 |
| Asset Turnover Ratio (%) | 2.51 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 14.09 | 8.80 | 6.42 |
| Total Current Assets Annual | 36.61 | 27.50 | 14.03 |
| Non Current Assets Annual | 18.18 | 8.80 | 8.46 |
| Total Shareholders Funds Annual | 20.99 | 7.10 | 4.81 |
| Total Assets Annual | 54.78 | 36.30 | 22.49 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 14.09 |
| Total Current Assets Annual | 36.61 |
| Non Current Assets Annual | 18.18 |
| Total Shareholders Funds Annual | 20.99 |
| Total Assets Annual | 54.78 |
EPS (INR)
Expected
0.42
Reported
0.42
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.76%
Dec 2023
EPS beaten by 0.68%
